← Open Payments lookup

DARREN KEMPTON: Open Payments

NPI 1902233208 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,861 in 19 payments from 10 companies in 2025. Trend: 2023 $741 · 2024 $910 · 2025 $1,861

Food & beverage: $1,861
CompanyPaymentsAmount
GENZYME CORPORATION5$556
UCB, Inc.4$332
Incyte Corporation2$264
ABBVIE INC.2$163
Amgen Inc.1$122
KYOWA KIRIN, INC.1$120
Boehringer Ingelheim Pharmaceuticals, Inc.1$97
Boston Scientific Corporation1$77
Access Pro Medical, LLC1$72
Janssen Scientific Affairs, LLC1$56

Products named: DUPIXENT, OPZELURA, Bimzelx, SKYRIZI, POTELIGEO, WAYRILZ, SPEVIGO, ACCOLADE SR.

Industry payments across TX — which companies pay providers there.